Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Hagedorn

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Genes|October 27, 2022
Episomes and Transposases-Utilities to Maintain Transgene Expression from Nonviral VectorsFlorian Kreppel, Claudia Hagedorn
International Journal of Molecular Sciences|March 6, 2021
Capsid and Genome Modification Strategies to Reduce the Immunogenicity of Adenoviral VectorsFlorian Kreppel, Claudia Hagedorn
Human Gene Therapy|September 1, 2017
Capsid Engineering of Adenovirus Vectors: Overcoming Early Vector-Host Interactions for TherapyClaudia Hagedorn, Florian Kreppel
Journal of Visualized Experiments : Jove|November 13, 2018
Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and TargetingFranziska Jönsson, Claudia Hagedorn, Florian Kreppel
Biomolecular Concepts|May 12, 2015
The epigenetic regulation of autonomous repliconsClaudia Hagedorn, Hans J Lipps, Sina Rupprecht
Molecular Therapy. Nucleic Acids|September 5, 2013
Genomic cis-acting Sequences Improve Expression and Establishment of a Nonviral VectorClaudia Hagedorn, Michael N Antoniou, Hans J Lipps
Methods in Molecular Biology (Clifton, N.J.)|October 8, 2017
Establishment of the CRISPR/Cas9 System for Targeted Gene Disruption and Gene TaggingEric Ehrke-Schulz, Maren Schiwon, Claudia Hagedorn, et al.
Human Gene Therapy|June 8, 2011
Scaffold/matrix attached region-based nonviral episomal vectorsClaudia Hagedorn, Suet-Ping Wong, Richard Harbottle, et al.
Cold Spring Harbor Protocols|June 5, 2012
A colony-forming assay for determining the establishment efficiency of S/MAR-containing nonviral episomal expression vectorsClaudia Hagedorn, Armin Baiker, Jan Postberg, et al.
Current Gene Therapy|December 25, 2013
Viral hybrid-vectors for delivery of autonomous repliconsWenli Zhang, Claudia Hagedorn, Eric Schulz, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Genes|October 27, 2022
Episomes and Transposases-Utilities to Maintain Transgene Expression from Nonviral VectorsFlorian Kreppel, Claudia Hagedorn
International Journal of Molecular Sciences|March 6, 2021
Capsid and Genome Modification Strategies to Reduce the Immunogenicity of Adenoviral VectorsFlorian Kreppel, Claudia Hagedorn
Human Gene Therapy|September 1, 2017
Capsid Engineering of Adenovirus Vectors: Overcoming Early Vector-Host Interactions for TherapyClaudia Hagedorn, Florian Kreppel
Journal of Visualized Experiments : Jove|November 13, 2018
Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and TargetingFranziska Jönsson, Claudia Hagedorn, Florian Kreppel
Biomolecular Concepts|May 12, 2015
The epigenetic regulation of autonomous repliconsClaudia Hagedorn, Hans J Lipps, Sina Rupprecht
Molecular Therapy. Nucleic Acids|September 5, 2013
Genomic cis-acting Sequences Improve Expression and Establishment of a Nonviral VectorClaudia Hagedorn, Michael N Antoniou, Hans J Lipps
Methods in Molecular Biology (Clifton, N.J.)|October 8, 2017
Establishment of the CRISPR/Cas9 System for Targeted Gene Disruption and Gene TaggingEric Ehrke-Schulz, Maren Schiwon, Claudia Hagedorn, et al.
Human Gene Therapy|June 8, 2011
Scaffold/matrix attached region-based nonviral episomal vectorsClaudia Hagedorn, Suet-Ping Wong, Richard Harbottle, et al.
Cold Spring Harbor Protocols|June 5, 2012
A colony-forming assay for determining the establishment efficiency of S/MAR-containing nonviral episomal expression vectorsClaudia Hagedorn, Armin Baiker, Jan Postberg, et al.
Current Gene Therapy|December 25, 2013
Viral hybrid-vectors for delivery of autonomous repliconsWenli Zhang, Claudia Hagedorn, Eric Schulz, et al.
Pageof 4